Complementary low-density lipoprotein-cholesterol lowering and pharmacokinetics of adding bempedoic acid (ETC-1002) to high-dose atorvastatin background therapy in hypercholesterolemic patients: A randomized placebo-controlled trial - Concepedia

Concepedia

Publication | Closed Access

Complementary low-density lipoprotein-cholesterol lowering and pharmacokinetics of adding bempedoic acid (ETC-1002) to high-dose atorvastatin background therapy in hypercholesterolemic patients: A randomized placebo-controlled trial

75

Citations

12

References

2019

Year

Narendra D. Lalwani, Jeffrey C. Hanselman, Diane MacDougall, Lulu Ren Sterling, Clay T. Cramer

Journal of clinical lipidology

Hypercholesterolemic PatientsCardiovascular DiseaseMedicineRandomized Placebo-controlled TrialHyperlipidemiaPharmacotherapyPharmacologyBempedoic AcidDyslipidemia

References

	Year	Citations

Page 1